Format

Send to

Choose Destination
Blood. 2015 Sep 10;126(11):1392-4. doi: 10.1182/blood-2015-05-647420.

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.

Author information

1
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
2
First Department of of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
3
Theageneion Cancer Center, Thessaloniki, Greece.
4
Department of Hematology, University of Patras School of Medicine, Patras, Greece.
5
Metaxa Cancer Center, Piraeus, Greece.
6
Department of Hematology, G. Genimatas Hospital, Athens, Greece.
7
Department of Hematology and Bone Marrow Transplant, Evangelismos Hospital, Athens, Greece.
8
School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
9
Second Department of Internal Medicine, National and Kapodistrian University of Athens, Haidari, Greece.
10
Department of Hematology, University of Ioannina School of Medicine, Ioannina, Greece.
11
Henry Dunant Hospital, Athens, Greece.
PMID:
26359434
DOI:
10.1182/blood-2015-05-647420
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center